Literature DB >> 21099104

Which species are in your feces?

Colby Zaph1.   

Abstract

Nosocomial infections (i.e., infections acquired as a result of treatment in a hospital or health care unit) result in approximately 100,000 deaths and cost more than 25 billion dollars per year in the US alone. These infections are caused primarily by bacteria and affect mainly immunosuppressed patients. However, not all patients acquire infections, and the events leading up to infection are unclear. In this issue of the JCI, Ubeda et al. report how acquisition of one such infection, vancomycin-resistant Enterococcus faecium (VRE), is linked to a shift in the microbial flora following antibiotic treatment. This study highlights the potential for high-throughput sequencing of intestinal microbiota as a means to identify high-risk populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099104      PMCID: PMC2993606          DOI: 10.1172/JCI45263

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  From the diet to the nucleus: vitamin A and TGF-beta join efforts at the mucosal interface of the intestine.

Authors:  Daniel Mucida; Yunji Park; Hilde Cheroutre
Journal:  Semin Immunol       Date:  2008-09-21       Impact factor: 11.130

Review 2.  The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses.

Authors:  Warren Strober
Journal:  Immunity       Date:  2009-09-18       Impact factor: 31.745

Review 3.  The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis.

Authors:  Michael C Abt; David Artis
Journal:  Curr Opin Gastroenterol       Date:  2009-11       Impact factor: 3.287

4.  Induction of intestinal Th17 cells by segmented filamentous bacteria.

Authors:  Ivaylo I Ivanov; Koji Atarashi; Nicolas Manel; Eoin L Brodie; Tatsuichiro Shima; Ulas Karaoz; Dongguang Wei; Katherine C Goldfarb; Clark A Santee; Susan V Lynch; Takeshi Tanoue; Akemi Imaoka; Kikuji Itoh; Kiyoshi Takeda; Yoshinori Umesaki; Kenya Honda; Dan R Littman
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

5.  Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection.

Authors:  Inna Sekirov; Nicola M Tam; Maria Jogova; Marilyn L Robertson; Yuling Li; Claudia Lupp; B Brett Finlay
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

6.  Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection.

Authors:  Amy Croswell; Elad Amir; Paul Teggatz; Melissa Barman; Nita H Salzman
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

7.  Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection.

Authors:  Cherilyn D Garner; Dionysios A Antonopoulos; Bettina Wagner; Gerald E Duhamel; Ivan Keresztes; Deborah A Ross; Vincent B Young; Craig Altier
Journal:  Infect Immun       Date:  2009-05-11       Impact factor: 3.441

8.  Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.

Authors:  Katharina Brandl; George Plitas; Coralia N Mihu; Carles Ubeda; Ting Jia; Martin Fleisher; Bernd Schnabl; Ronald P DeMatteo; Eric G Pamer
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

9.  Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis.

Authors:  D A Hill; C Hoffmann; M C Abt; Y Du; D Kobuley; T J Kirn; F D Bushman; D Artis
Journal:  Mucosal Immunol       Date:  2009-11-25       Impact factor: 7.313

10.  The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.

Authors:  Les Dethlefsen; Sue Huse; Mitchell L Sogin; David A Relman
Journal:  PLoS Biol       Date:  2008-11-18       Impact factor: 8.029

View more
  6 in total

1.  Sodium caseinate induces mouse granulopoiesis.

Authors:  V Domínguez-Melendez; O Silvestre-Santana; L Moreno-Fierros; I Aguiñiga-Sánchez; Ledesma Martínez; R Marroquin-Segura; A L García-Hernández; B Weiss-Steider; A Marché-Cova; A Monroy-García; L Mora-García; Edelmiro Santiago-Osorio
Journal:  Inflamm Res       Date:  2012-01-20       Impact factor: 4.575

Review 2.  The rise of the Enterococcus: beyond vancomycin resistance.

Authors:  Cesar A Arias; Barbara E Murray
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

Review 3.  The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance.

Authors:  Melinda M Pettigrew; J Kristie Johnson; Anthony D Harris
Journal:  Ann Epidemiol       Date:  2016-03-08       Impact factor: 3.797

Review 4.  Routine use of microbial whole genome sequencing in diagnostic and public health microbiology.

Authors:  Claudio U Köser; Matthew J Ellington; Edward J P Cartwright; Stephen H Gillespie; Nicholas M Brown; Mark Farrington; Matthew T G Holden; Gordon Dougan; Stephen D Bentley; Julian Parkhill; Sharon J Peacock
Journal:  PLoS Pathog       Date:  2012-08-02       Impact factor: 6.823

5.  Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice.

Authors:  Andres Gomez; David Luckey; Carl J Yeoman; Eric V Marietta; Margret E Berg Miller; Joseph A Murray; Bryan A White; Veena Taneja
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

6.  Patho-Genes.org: a website dedicated to gene sequences of potential bioterror bacteria and PCR primers used to amplify them.

Authors:  Julien Gardès; Dipankar Bachar; Olivier Croce; Richard Christen
Journal:  Microb Biotechnol       Date:  2012-06-10       Impact factor: 5.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.